Fox Chase Cancer Center’s Post

Slightly outside of the current GenAI & Machine Vision spotlight, researchers here have used an unsupervised single hidden layer NN model to determine there are two distinct types of prostate cancer, formed by two different evolutionary trajectories. Shared below from PharmaTimes https://lnkd.in/eF5RqA6A, their paper is also published in full here https://lnkd.in/epgSNxFu

Are you curious about joining Cancer Crosslinks next year? Read about the exciting day, and see the highlights from Cancer Crosslinks 2024 in this picture special!

🌐 Discover the secrets of navigating the intricate maze of tumors in a 3D environment. 🧬 Our latest article unravels the complexities of cancer research, offering a scientific adventure that's both educational and fun! Read now. #thermofisheremp

🌐 Discover the secrets of navigating the intricate maze of tumors in a 3D environment. 🧬 Our latest article unravels the complexities of cancer research, offering a scientific adventure that's both educational and fun! Read now. #thermofisheremp

🚨 In a groundbreaking development in cancer research, Cancer Research UK,Cell Genomics @CellGenomics, has unveiled a pivotal study that challenges the notion of prostate cancer as a singular disease. Utilizing the power of artificial intelligence, researchers have delved deep into the intricate complexities of prostate cancer, revealing a spectrum of variations that demand personalized approaches to treatment. This significant breakthrough marks a paradigm shift in our understanding of the disease, offering new insights into its diverse manifestations and paving the way for tailored treatment strategies. This revelation underscores the importance of harnessing cutting-edge technology to decode the intricacies of cancer biology and develop targeted interventions that address the unique characteristics of each patient's cancer. By recognizing that prostate cancer is not a uniform entity but rather a spectrum of distinct subtypes, researchers are poised to revolutionize how we approach diagnosis, prognosis, and treatment decisions. However, amidst this groundbreaking discovery, it's crucial not to overlook the critical role of early detection. Men, heed the call: prioritize regular check-ups and screenings. Early detection remains our most potent weapon in the fight against prostate cancer, offering the best chance for successful treatment outcomes and improved survival rates. Let's unite in the battle against cancer and ensure that every individual receives the care and support they need to thrive. @NDSurgicalSci, Nuffield Department of Surgical Sciences at the University of Oxford https://buff.ly/3T2Mkoi

https://lnkd.in/d4wxhPki 🔬Excited to share our latest quiz on the 'Classification of Cancer'! Test your knowledge and explore the world of Molecular Cancer Biology, oncology with insightful questions. Challenge yourself and learn more about cancer types, staging, and grading. #ClassificationOfCancerquiz #OncologyQuiz #TheScholarPost

🎗️ National Cancer Research Month may come just once a year, but JAX is working every day to advance #oncology. This JAX blog post touches on two factors necessary to usher in the next wave of progress in #CancerResearch: embracing the lessons of cancer biology in the lab and striving toward improved patient #CancerTreatment access:

🌐 Discover the secrets of navigating the intricate maze of tumors in a 3D environment. 🧬 Our latest article unravels the complexities of cancer research, offering a scientific adventure that's both educational and fun! Read now. #thermofisheremp

May is National Cancer Research Month. Since 1999, after Harold “Hal” Eisenberg lost his life to liver and pancreatic cancers, the Harold E. Eisenberg Foundation has honored his memory by funding breakthrough research to fight gastrointestinal (GI) cancers and increase survivorship. In partnership with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, the Eisenberg Foundation has supported critical efforts to move forward GI cancer research. More than 500 samples in the Harold E. Eisenberg GI Cancer Tissue Bank have been sequenced, and with these results, physicians and scientists will have both pathology and genomic characterizations of these colon cancer samples. Learn more about this important work at:  https://lnkd.in/gMJvU3Ke